Novakovitch G - Search Results

1

Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.

Chabannon C, Le Corroller AG, Viret F, Eillen C, Faucher C, Moatti JP, Viens P, Vey N, Braud AC, Novakovitch G, Ladaique P, Stoppa AM, Camerlo J, Genre D, Maraninchi D, Blaise D. Chabannon C, et al. Among authors: novakovitch g. Leukemia. 2003 Apr;17(4):811-3. doi: 10.1038/sj.leu.2402867. Leukemia. 2003. PMID: 12682645 No abstract available.

2

Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recovery.

Vey N, Molnar S, Faucher C, Le Corroller AG, Stoppa AM, Viens P, Bouabdallah R, Camerlo J, Novakovitch G, Mannoni P, et al. Vey N, et al. Among authors: novakovitch g. Bone Marrow Transplant. 1994 Nov;14(5):779-82. Bone Marrow Transplant. 1994. PMID: 7534161 Clinical Trial.

3

Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness.

Faucher C, le Corroller AG, Blaise D, Novakovitch G, Manonni P, Moatti JP, Maraninchi D. Faucher C, et al. Among authors: novakovitch g. Bone Marrow Transplant. 1994 Dec;14(6):895-901. Bone Marrow Transplant. 1994. PMID: 7536070

4

Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: a randomized study.

Faucher C, Le Corroller AG, Chabannon C, Novakovitch G, Manonni P, Moatti JP, Nouyrigat P, Maraninchi D, Blaise D. Faucher C, et al. Among authors: novakovitch g. Bone Marrow Transplant. 1996 Apr;17(4):533-6. Bone Marrow Transplant. 1996. PMID: 8722350 Clinical Trial.

5

Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery.

Faucher C, Le Corroller AG, Chabannon C, Viens P, Stoppa AM, Bouabdallah R, Camerlo J, Vey N, Gravis G, Gastaut JA, Novakovitch G, Mannoni P, Bardou VJ, Moatti JP, Maraninchi D, Blaise D. Faucher C, et al. Among authors: novakovitch g. J Hematother. 1996 Dec;5(6):663-70. doi: 10.1089/scd.1.1996.5.663. J Hematother. 1996. PMID: 9117255

6

Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma.

Stoppa AM, Bouabdallah R, Chabannon C, Novakovitch G, Vey N, Camerlo J, Blaise D, Xerri L, Resbeut M, Di Stefano D, Bardou VJ, Gastaut JA, Maraninchi D. Stoppa AM, et al. Among authors: novakovitch g. J Clin Oncol. 1997 May;15(5):1722-9. doi: 10.1200/JCO.1997.15.5.1722. J Clin Oncol. 1997. PMID: 9164178

7

Benefits of granulocyte-colony-stimulating factor after stem cell transfusion in intensive sequential chemotherapy for breast cancer.

Viens P, Genre D, Protière C, Gravis G, Bertucci F, Cowen D, Camerlo J, Chabannon C, Novakovitch G, Conte M, Finaud M, Moatti JP, Maraninchi D. Viens P, et al. Among authors: novakovitch g. Eur Cytokine Netw. 1998 Mar;9(1):93-8. Eur Cytokine Netw. 1998. PMID: 9613683 Free article. Clinical Trial.

8

Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement.

Viret F, Blaise D, Bouabdallah R, Stoppa AM, Novakovitch G, Faucher C, Vey N, Camerlo J, Oziel-Taieb S, Ladaique P, Gastaut JA, Maraninchi D, Chabannon C. Viret F, et al. Among authors: novakovitch g. Hematol Cell Ther. 1999 Feb;41(1):5-11. doi: 10.1007/s00282-999-0005-y. Hematol Cell Ther. 1999. PMID: 10193640

9

The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell technology.

Chabannon C, Novakovitch G, Blache JL, Olivero S, Camerlo J, Genre D, Maraninchi D, Viens P. Chabannon C, et al. Among authors: novakovitch g. Hematol Cell Ther. 1999 Apr;41(2):78-81. doi: 10.1007/s00282-999-0078-7. Hematol Cell Ther. 1999. PMID: 10344557

10

Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: a phase I-II study.

Genre D, Viens P, Gravis G, Bertucci F, Cowen D, Novakovitch G, Derméche S, Chabannon C, Oziel-Taieb S, Camerlo J, Houvenaeghel G, Jacquemier J, Maraninchi D. Genre D, et al. Among authors: novakovitch g. Anticancer Res. 2000 May-Jun;20(3B):2033-40. Anticancer Res. 2000. PMID: 10928147 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters